| Tallahassee Democrat
Tallahassee Memorial HealthCare (TMH), in partnership with The Village Square and USA TODAY NETWORK-Florida, is proud to present a virtual conversation about COVID-19 vaccine development and safety called “Journey of a COVID Vaccine,” featuring two nationally acclaimed members of the U.S. Food and Drug Administration’s (FDA) Vaccine and Related Biological Products Advisory Committee.
This free, virtual event will be at 1 p.m. EST Wednesday, Jan. 13, via Zoom and Facebook Live.
The event will feature insight from vaccine experts Dr. Paul Spearman, director of the division of infectious diseases at Cincinnati Children’s Hospital Medical Center, and Dr. Geeta Swamy, associate vice president for research at Duke University, who both sit on the FDA’s Vaccine and Related Biological Products Advisory Committee.
This core group reviews and evaluates research, safety, effectiveness and appropriate use of vaccines intended for the prevention and treatment of human diseases, as required by the FDA.
As the first wave of COVID-19 vaccines is rolled-out across the country, Dr. Spearman and Dr. Swamy will take the virtual stage for a candid and informative Q&A style discussion during this monumental time in our nation’s history.
The discussion will be moderated by former Tallahassee Democrat publisher Skip Foster.
The doctors will answer frequently asked questions about COVID-19 vaccines and will provide regional and national audiences the information they need to make informed decisions regarding the COVID-19 vaccines and how to prevent the spread of the virus.
The discussion will also be streamed on Facebook Live on USA TODAY NETWORK newspaper Facebook pages around Florida, including the Tallahassee Democrat’s site.
If you have a question you’d like to submit email email@example.com.
This virtual event is also open to the public on Zoom and registration is required to submit questions live during the Zoom event. Visit TMH.ORG/CovidTalk to sign up.
Never miss a story: Subscribe to the Tallahassee Democrat using the link at the top of the page.